文献速递白血病造血干细胞移植与细胞治疗

间充质基质细胞AKR1C1上调促进急性髓系白血病细胞存活

Upregulation of AKR1C1 in mesenchymal stromal cells promotes the survival of acute myeloid leukaemia cells.
PubMed 文献 · Br J Haematol · 2020-01-14

该研究通过生物信息学分析发现AML患者间充质基质细胞中AKR1C1显著上调;敲低AKR1C1可抑制MSC成脂分化、促进成骨并抑制共培养AML细胞生长,机制涉及MCP-1、IL-6、G-CSF分泌减少及STAT3、ERK1/2失活。

要点

  • AML-MSC中AKR1C1显著上调,驱动成脂分化并支持AML细胞存活。
  • 敲低AKR1C1可抑制成脂、促进成骨并抑制共培养AML细胞生长。
  • AKR1C1通过促进MCP-1、IL-6、G-CSF分泌及STAT3/ERK1/2活化发挥作用。

核心结论

  • AKR1C1是驱动白血病MSC成脂分化的关键因子,并通过促进细胞因子分泌和激活AML细胞下游通路介导促存活效应。

研究设计与样本

  • 研究对AML患者来源MSC进行生物信息学分析,共鉴定271个与成脂分化相关的异常表达基因。

主要发现

  • 在AML-MSC中AKR1C1显著上调。
  • 敲低MSC中AKR1C1抑制成脂分化、促进成骨,并抑制共培养AML细胞系生长。
  • 在MSC中引入重组人AKR1C1可部分缓解敲低AKR1C1的效应。
  • 敲低AKR1C1减少MSC分泌MCP-1、IL-6和G-CSF,并伴随共培养AML细胞中STAT3和ERK1/2失活。

关键数值与推荐

  • 在AML患者来源MSC中鉴定出271个与成脂分化相关的异常表达基因。
  • AKR1C1在AML-MSC中显著上调。

临床怎么用

  • AKR1C1可能作为靶向白血病骨髓微环境的潜在干预靶点,但尚需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The leukaemic bone marrow microenvironment, comprising abnormal mesenchymal stromal cells (MSCs), is responsible for the poor prognosis of acute myeloid leukaemia (AML). Therefore, it is essential to determine the mechanisms underlying the supportive role of MSCs in the survival of leukaemia cells. Through in silico analyses, we identified a total of 271 aberrantly expressed genes in the MSCs derived from acute myeloid leukemia (AML) patients that were associated with adipogenic differentiation, of which aldo-keto reductase 1C1 (AKR1C1) was significantly upregulated in the AML-MSCs. Knockdown of AKR1C1 in the MSCs suppressed adipogenesis and promoted osteogenesis, and inhibited the growth of co-cultured AML cell lines compared to the situation in wild- type AML-derived MSCs. Introduction of recombinant human AKR1C1 in the MSCs partially alleviated the effects of AKR1C1 knockdown. In addition, the absence of AKR1C1 reduced secretion of cytokines such as MCP-1, IL-6 and G-CSF from the MSCs, along with inactivation of STAT3 and ERK1/2 in the co-cultured AML cells. AKR1C1 is an essential factor driving the adipogenic differentiation of leukaemic MSCs and mediates its pro-survival effects on AML cells by promoting cytokine secretion and activating the downstream pathways in the AML cells.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Jiang Y, Li Y, Cheng J, et al. Upregulation of AKR1C1 in mesenchymal stromal cells promotes the survival of acute myeloid leukaemia cells. Br J Haematol. 2020. PMID: 31943135. doi:10.1111/bjh.16253

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。